nodes	percent_of_prediction	percent_of_DWPC	metapath
Glyburide—CYP2C9—brain cancer	0.439	1	CbGaD
Glyburide—ABCC3—Etoposide—brain cancer	0.0731	0.22	CbGbCtD
Glyburide—ABCC1—Etoposide—brain cancer	0.0449	0.135	CbGbCtD
Glyburide—ABCC2—Carboplatin—brain cancer	0.0396	0.119	CbGbCtD
Glyburide—ABCG2—Carboplatin—brain cancer	0.0358	0.108	CbGbCtD
Glyburide—ABCC2—Etoposide—brain cancer	0.0332	0.1	CbGbCtD
Glyburide—CYP3A4—Temozolomide—brain cancer	0.0316	0.095	CbGbCtD
Glyburide—ABCG2—Etoposide—brain cancer	0.0301	0.0904	CbGbCtD
Glyburide—CYP3A4—Lomustine—brain cancer	0.0269	0.0808	CbGbCtD
Glyburide—ABCB1—Etoposide—brain cancer	0.0108	0.0326	CbGbCtD
Glyburide—CFTR—nose—brain cancer	0.0106	0.132	CbGeAlD
Glyburide—CYP3A4—Etoposide—brain cancer	0.00649	0.0195	CbGbCtD
Glyburide—SLC15A2—choroid plexus—brain cancer	0.0061	0.0759	CbGeAlD
Glyburide—KCNJ5—hindbrain—brain cancer	0.00468	0.0582	CbGeAlD
Glyburide—Myelosuppression—Lomustine—brain cancer	0.00443	0.0437	CcSEcCtD
Glyburide—Blindness—Lomustine—brain cancer	0.00375	0.037	CcSEcCtD
Glyburide—KCNJ5—brainstem—brain cancer	0.00268	0.0334	CbGeAlD
Glyburide—ABCA1—blood vessel—brain cancer	0.00252	0.0313	CbGeAlD
Glyburide—Myelosuppression—Hydroxyurea—brain cancer	0.00217	0.0215	CcSEcCtD
Glyburide—KCNJ5—pituitary gland—brain cancer	0.00194	0.0241	CbGeAlD
Glyburide—Myelosuppression—Carmustine—brain cancer	0.00176	0.0174	CcSEcCtD
Glyburide—Myelosuppression—Temozolomide—brain cancer	0.0017	0.0168	CcSEcCtD
Glyburide—Eruption—Hydroxyurea—brain cancer	0.00166	0.0164	CcSEcCtD
Glyburide—Visual disturbance—Lomustine—brain cancer	0.00159	0.0157	CcSEcCtD
Glyburide—Digestion impaired—Hydroxyurea—brain cancer	0.00153	0.0151	CcSEcCtD
Glyburide—KCNJ5—endocrine gland—brain cancer	0.0015	0.0187	CbGeAlD
Glyburide—KCNJ5—head—brain cancer	0.00148	0.0184	CbGeAlD
Glyburide—SLCO2B1—ganglion—brain cancer	0.00146	0.0181	CbGeAlD
Glyburide—Myelosuppression—Etoposide—brain cancer	0.00136	0.0134	CcSEcCtD
Glyburide—KCNJ5—central nervous system—brain cancer	0.00135	0.0168	CbGeAlD
Glyburide—Nephropathy—Etoposide—brain cancer	0.00134	0.0132	CcSEcCtD
Glyburide—KCNJ5—cerebellum—brain cancer	0.00132	0.0164	CbGeAlD
Glyburide—CPT1A—telencephalon—brain cancer	0.00131	0.0163	CbGeAlD
Glyburide—KCNJ1—telencephalon—brain cancer	0.00128	0.016	CbGeAlD
Glyburide—Encephalopathy—Carmustine—brain cancer	0.00128	0.0127	CcSEcCtD
Glyburide—Pancytopenia—Lomustine—brain cancer	0.00124	0.0122	CcSEcCtD
Glyburide—ABCA1—telencephalon—brain cancer	0.00122	0.0152	CbGeAlD
Glyburide—Digestion impaired—Temozolomide—brain cancer	0.00119	0.0118	CcSEcCtD
Glyburide—Gliclazide—VEGFA—brain cancer	0.00111	0.198	CrCbGaD
Glyburide—CPT1A—gonad—brain cancer	0.00109	0.0136	CbGeAlD
Glyburide—Hepatic function abnormal—Procarbazine—brain cancer	0.00109	0.0108	CcSEcCtD
Glyburide—KCNJ5—brain—brain cancer	0.00107	0.0134	CbGeAlD
Glyburide—Deafness—Procarbazine—brain cancer	0.00107	0.0106	CcSEcCtD
Glyburide—Vascular purpura—Procarbazine—brain cancer	0.00107	0.0106	CcSEcCtD
Glyburide—Haemolytic anaemia—Procarbazine—brain cancer	0.00106	0.0105	CcSEcCtD
Glyburide—Glimepiride—CYP2C9—brain cancer	0.00106	0.189	CrCbGaD
Glyburide—Cholestasis—Temozolomide—brain cancer	0.00105	0.0104	CcSEcCtD
Glyburide—Coagulopathy—Temozolomide—brain cancer	0.00102	0.0101	CcSEcCtD
Glyburide—Visual impairment—Lomustine—brain cancer	0.001	0.00992	CcSEcCtD
Glyburide—Purpura—Procarbazine—brain cancer	0.000992	0.0098	CcSEcCtD
Glyburide—Zafirlukast—CYP2C9—brain cancer	0.000989	0.177	CrCbGaD
Glyburide—Diplopia—Procarbazine—brain cancer	0.000956	0.00944	CcSEcCtD
Glyburide—Alopecia—Lomustine—brain cancer	0.000921	0.00909	CcSEcCtD
Glyburide—Glipizide—CYP2C9—brain cancer	0.000915	0.164	CrCbGaD
Glyburide—Hyperbilirubinaemia—Temozolomide—brain cancer	0.000876	0.00865	CcSEcCtD
Glyburide—ABCA1—spinal cord—brain cancer	0.000856	0.0107	CbGeAlD
Glyburide—Gliclazide—CYP2C9—brain cancer	0.000851	0.153	CrCbGaD
Glyburide—CPT1A—endocrine gland—brain cancer	0.000827	0.0103	CbGeAlD
Glyburide—Hepatic failure—Hydroxyurea—brain cancer	0.000824	0.00813	CcSEcCtD
Glyburide—Eosinophilia—Procarbazine—brain cancer	0.000818	0.00808	CcSEcCtD
Glyburide—CPT1A—head—brain cancer	0.000817	0.0102	CbGeAlD
Glyburide—ABCC9—brain—brain cancer	0.000814	0.0101	CbGeAlD
Glyburide—Leukopenia—Lomustine—brain cancer	0.000812	0.00802	CcSEcCtD
Glyburide—Pancreatitis—Procarbazine—brain cancer	0.00081	0.008	CcSEcCtD
Glyburide—ABCC8—brainstem—brain cancer	0.000809	0.0101	CbGeAlD
Glyburide—Sweating increased—Procarbazine—brain cancer	0.000805	0.00795	CcSEcCtD
Glyburide—Renal failure acute—Hydroxyurea—brain cancer	0.000802	0.00792	CcSEcCtD
Glyburide—KCNJ1—head—brain cancer	0.0008	0.00995	CbGeAlD
Glyburide—Pancytopenia—Procarbazine—brain cancer	0.000785	0.00775	CcSEcCtD
Glyburide—Dermatitis bullous—Hydroxyurea—brain cancer	0.000774	0.00765	CcSEcCtD
Glyburide—ABCA1—endocrine gland—brain cancer	0.000771	0.00959	CbGeAlD
Glyburide—ABCA1—head—brain cancer	0.000761	0.00947	CbGeAlD
Glyburide—Photosensitivity reaction—Procarbazine—brain cancer	0.000755	0.00745	CcSEcCtD
Glyburide—Aplastic anaemia—Temozolomide—brain cancer	0.000748	0.00739	CcSEcCtD
Glyburide—KCNJ1—central nervous system—brain cancer	0.00073	0.00909	CbGeAlD
Glyburide—CPT1A—cerebellum—brain cancer	0.000729	0.00907	CbGeAlD
Glyburide—CFTR—endocrine gland—brain cancer	0.000728	0.00906	CbGeAlD
Glyburide—Thrombocytopenia—Lomustine—brain cancer	0.000725	0.00716	CcSEcCtD
Glyburide—CFTR—head—brain cancer	0.000719	0.00895	CbGeAlD
Glyburide—Jaundice—Procarbazine—brain cancer	0.000718	0.00709	CcSEcCtD
Glyburide—ABCC8—telencephalon—brain cancer	0.000718	0.00893	CbGeAlD
Glyburide—Anorexia—Lomustine—brain cancer	0.000706	0.00697	CcSEcCtD
Glyburide—ABCA1—central nervous system—brain cancer	0.000695	0.00864	CbGeAlD
Glyburide—ABCA1—cerebellum—brain cancer	0.000679	0.00845	CbGeAlD
Glyburide—Chlorpropamide—CYP2C9—brain cancer	0.000662	0.119	CrCbGaD
Glyburide—Deafness—Temozolomide—brain cancer	0.000646	0.00638	CcSEcCtD
Glyburide—Vascular purpura—Temozolomide—brain cancer	0.000646	0.00638	CcSEcCtD
Glyburide—Decreased appetite—Lomustine—brain cancer	0.000644	0.00636	CcSEcCtD
Glyburide—Hepatic failure—Temozolomide—brain cancer	0.000643	0.00635	CcSEcCtD
Glyburide—Pancreatitis—Hydroxyurea—brain cancer	0.000627	0.00619	CcSEcCtD
Glyburide—Pancytopenia—Hydroxyurea—brain cancer	0.000608	0.006	CcSEcCtD
Glyburide—Hyponatraemia—Carmustine—brain cancer	0.000601	0.00593	CcSEcCtD
Glyburide—Purpura—Temozolomide—brain cancer	0.0006	0.00592	CcSEcCtD
Glyburide—Diplopia—Carmustine—brain cancer	0.000598	0.00591	CcSEcCtD
Glyburide—ABCB11—endocrine gland—brain cancer	0.000597	0.00743	CbGeAlD
Glyburide—CPT1A—brain—brain cancer	0.000592	0.00737	CbGeAlD
Glyburide—Alopecia—Procarbazine—brain cancer	0.000585	0.00577	CcSEcCtD
Glyburide—ABCC8—pituitary gland—brain cancer	0.000584	0.00727	CbGeAlD
Glyburide—KCNJ1—brain—brain cancer	0.00058	0.00721	CbGeAlD
Glyburide—Diplopia—Temozolomide—brain cancer	0.000578	0.00571	CcSEcCtD
Glyburide—ABCC8—medulla oblongata—brain cancer	0.000564	0.00702	CbGeAlD
Glyburide—SLCO2B1—telencephalon—brain cancer	0.000562	0.00699	CbGeAlD
Glyburide—ABCA1—brain—brain cancer	0.000551	0.00686	CbGeAlD
Glyburide—Tremor—Procarbazine—brain cancer	0.00054	0.00533	CcSEcCtD
Glyburide—SLC22A7—endocrine gland—brain cancer	0.000539	0.0067	CbGeAlD
Glyburide—Anaemia—Procarbazine—brain cancer	0.000532	0.00526	CcSEcCtD
Glyburide—CFTR—brain—brain cancer	0.000521	0.00648	CbGeAlD
Glyburide—SLCO1A2—telencephalon—brain cancer	0.000517	0.00643	CbGeAlD
Glyburide—Leukopenia—Procarbazine—brain cancer	0.000516	0.00509	CcSEcCtD
Glyburide—ABCC8—midbrain—brain cancer	0.000515	0.00641	CbGeAlD
Glyburide—Abdominal distension—Temozolomide—brain cancer	0.000503	0.00497	CcSEcCtD
Glyburide—ABCC8—spinal cord—brain cancer	0.000503	0.00626	CbGeAlD
Glyburide—Convulsion—Procarbazine—brain cancer	0.000499	0.00493	CcSEcCtD
Glyburide—KCNJ11—endocrine gland—brain cancer	0.000491	0.00612	CbGeAlD
Glyburide—Pancytopenia—Carmustine—brain cancer	0.000491	0.00485	CcSEcCtD
Glyburide—Arthralgia—Procarbazine—brain cancer	0.00049	0.00484	CcSEcCtD
Glyburide—Myalgia—Procarbazine—brain cancer	0.00049	0.00484	CcSEcCtD
Glyburide—Sweating increased—Temozolomide—brain cancer	0.000487	0.00481	CcSEcCtD
Glyburide—KCNJ11—head—brain cancer	0.000485	0.00604	CbGeAlD
Glyburide—Pancytopenia—Temozolomide—brain cancer	0.000475	0.00469	CcSEcCtD
Glyburide—Confusional state—Procarbazine—brain cancer	0.000474	0.00468	CcSEcCtD
Glyburide—Vomiting—Lomustine—brain cancer	0.000471	0.00465	CcSEcCtD
Glyburide—Oedema—Procarbazine—brain cancer	0.00047	0.00464	CcSEcCtD
Glyburide—Shock—Procarbazine—brain cancer	0.000462	0.00457	CcSEcCtD
Glyburide—Thrombocytopenia—Procarbazine—brain cancer	0.00046	0.00454	CcSEcCtD
Glyburide—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000459	0.0111	CbGpPWpGaD
Glyburide—Photosensitivity reaction—Temozolomide—brain cancer	0.000456	0.0045	CcSEcCtD
Glyburide—CPT1A—Circadian rythm related genes—NTRK3—brain cancer	0.000455	0.011	CbGpPWpGaD
Glyburide—Hyperhidrosis—Procarbazine—brain cancer	0.000454	0.00449	CcSEcCtD
Glyburide—ABCC8—endocrine gland—brain cancer	0.000453	0.00563	CbGeAlD
Glyburide—Alopecia—Hydroxyurea—brain cancer	0.000452	0.00447	CcSEcCtD
Glyburide—ABCC1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000452	0.011	CbGpPWpGaD
Glyburide—Anorexia—Procarbazine—brain cancer	0.000448	0.00442	CcSEcCtD
Glyburide—ABCC8—head—brain cancer	0.000447	0.00556	CbGeAlD
Glyburide—Erythema—Hydroxyurea—brain cancer	0.000446	0.0044	CcSEcCtD
Glyburide—KCNJ11—central nervous system—brain cancer	0.000443	0.00551	CbGeAlD
Glyburide—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000441	0.0107	CbGpPWpGaD
Glyburide—SLCO2B1—medulla oblongata—brain cancer	0.000441	0.00549	CbGeAlD
Glyburide—Nausea—Lomustine—brain cancer	0.00044	0.00434	CcSEcCtD
Glyburide—Hypotension—Procarbazine—brain cancer	0.000439	0.00434	CcSEcCtD
Glyburide—ABCA1—Vitamin B12 Metabolism—SOD2—brain cancer	0.000435	0.0106	CbGpPWpGaD
Glyburide—KCNJ11—cerebellum—brain cancer	0.000433	0.00539	CbGeAlD
Glyburide—SLC15A1—endocrine gland—brain cancer	0.000433	0.00539	CbGeAlD
Glyburide—SLC15A2—telencephalon—brain cancer	0.000429	0.00534	CbGeAlD
Glyburide—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000428	0.00423	CcSEcCtD
Glyburide—ABCC1—telencephalon—brain cancer	0.000424	0.00528	CbGeAlD
Glyburide—Paraesthesia—Procarbazine—brain cancer	0.000422	0.00417	CcSEcCtD
Glyburide—Anaemia—Hydroxyurea—brain cancer	0.000412	0.00407	CcSEcCtD
Glyburide—Decreased appetite—Procarbazine—brain cancer	0.000409	0.00403	CcSEcCtD
Glyburide—ABCC8—central nervous system—brain cancer	0.000408	0.00508	CbGeAlD
Glyburide—SLCO1A2—medulla oblongata—brain cancer	0.000406	0.00505	CbGeAlD
Glyburide—CFTR—Transmembrane transport of small molecules—S100A10—brain cancer	0.000404	0.00979	CbGpPWpGaD
Glyburide—Hepatitis—Temozolomide—brain cancer	0.0004	0.00395	CcSEcCtD
Glyburide—Leukopenia—Hydroxyurea—brain cancer	0.000399	0.00394	CcSEcCtD
Glyburide—Visual impairment—Carmustine—brain cancer	0.000399	0.00394	CcSEcCtD
Glyburide—ABCC8—cerebellum—brain cancer	0.000399	0.00496	CbGeAlD
Glyburide—SLCO2B1—spinal cord—brain cancer	0.000394	0.0049	CbGeAlD
Glyburide—ABCB11—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000392	0.00951	CbGpPWpGaD
Glyburide—Sweating increased—Etoposide—brain cancer	0.00039	0.00385	CcSEcCtD
Glyburide—Feeling abnormal—Procarbazine—brain cancer	0.000387	0.00382	CcSEcCtD
Glyburide—Eye disorder—Carmustine—brain cancer	0.000387	0.00382	CcSEcCtD
Glyburide—Convulsion—Hydroxyurea—brain cancer	0.000386	0.00381	CcSEcCtD
Glyburide—Visual impairment—Temozolomide—brain cancer	0.000386	0.00381	CcSEcCtD
Glyburide—SLC22A7—brain—brain cancer	0.000385	0.0048	CbGeAlD
Glyburide—Gastrointestinal pain—Procarbazine—brain cancer	0.000384	0.0038	CcSEcCtD
Glyburide—ABCC3—endocrine gland—brain cancer	0.00038	0.00473	CbGeAlD
Glyburide—Pancytopenia—Etoposide—brain cancer	0.00038	0.00375	CcSEcCtD
Glyburide—CPT1A—PPAR Alpha Pathway—CCND1—brain cancer	0.000378	0.00918	CbGpPWpGaD
Glyburide—ABCC3—head—brain cancer	0.000375	0.00467	CbGeAlD
Glyburide—Eye disorder—Temozolomide—brain cancer	0.000374	0.00369	CcSEcCtD
Glyburide—Urticaria—Procarbazine—brain cancer	0.000373	0.00369	CcSEcCtD
Glyburide—SLC22A6—brain—brain cancer	0.000372	0.00463	CbGeAlD
Glyburide—Abdominal pain—Procarbazine—brain cancer	0.000372	0.00367	CcSEcCtD
Glyburide—SLCO1A2—midbrain—brain cancer	0.000371	0.00462	CbGeAlD
Glyburide—Alopecia—Carmustine—brain cancer	0.000366	0.00361	CcSEcCtD
Glyburide—Oedema—Hydroxyurea—brain cancer	0.000364	0.00359	CcSEcCtD
Glyburide—SLCO1A2—spinal cord—brain cancer	0.000362	0.00451	CbGeAlD
Glyburide—Malnutrition—Carmustine—brain cancer	0.00036	0.00356	CcSEcCtD
Glyburide—Erythema—Carmustine—brain cancer	0.00036	0.00356	CcSEcCtD
Glyburide—ABCB1—blood vessel—brain cancer	0.000357	0.00444	CbGeAlD
Glyburide—Nervous system disorder—Hydroxyurea—brain cancer	0.000357	0.00352	CcSEcCtD
Glyburide—Thrombocytopenia—Hydroxyurea—brain cancer	0.000356	0.00352	CcSEcCtD
Glyburide—SLCO2B1—endocrine gland—brain cancer	0.000354	0.00441	CbGeAlD
Glyburide—ABCA1—Folate Metabolism—SOD2—brain cancer	0.000354	0.00859	CbGpPWpGaD
Glyburide—Alopecia—Temozolomide—brain cancer	0.000353	0.00349	CcSEcCtD
Glyburide—KCNJ11—brain—brain cancer	0.000352	0.00438	CbGeAlD
Glyburide—ABCG2—telencephalon—brain cancer	0.000351	0.00437	CbGeAlD
Glyburide—SLCO2B1—head—brain cancer	0.00035	0.00435	CbGeAlD
Glyburide—SLC15A2—pituitary gland—brain cancer	0.000349	0.00435	CbGeAlD
Glyburide—Erythema—Temozolomide—brain cancer	0.000348	0.00344	CcSEcCtD
Glyburide—Malnutrition—Temozolomide—brain cancer	0.000348	0.00344	CcSEcCtD
Glyburide—Jaundice—Etoposide—brain cancer	0.000348	0.00343	CcSEcCtD
Glyburide—Anorexia—Hydroxyurea—brain cancer	0.000347	0.00342	CcSEcCtD
Glyburide—Hypersensitivity—Procarbazine—brain cancer	0.000346	0.00342	CcSEcCtD
Glyburide—ABCC1—pituitary gland—brain cancer	0.000345	0.0043	CbGeAlD
Glyburide—ABCC3—central nervous system—brain cancer	0.000343	0.00426	CbGeAlD
Glyburide—Vision blurred—Carmustine—brain cancer	0.00034	0.00335	CcSEcCtD
Glyburide—Tremor—Carmustine—brain cancer	0.000338	0.00333	CcSEcCtD
Glyburide—Asthenia—Procarbazine—brain cancer	0.000337	0.00333	CcSEcCtD
Glyburide—SLC15A2—medulla oblongata—brain cancer	0.000337	0.00419	CbGeAlD
Glyburide—ABCC2—Irinotecan Pathway—APC—brain cancer	0.000336	0.00815	CbGpPWpGaD
Glyburide—Anaemia—Carmustine—brain cancer	0.000333	0.00329	CcSEcCtD
Glyburide—Agranulocytosis—Etoposide—brain cancer	0.000333	0.00329	CcSEcCtD
Glyburide—Pruritus—Procarbazine—brain cancer	0.000333	0.00328	CcSEcCtD
Glyburide—ABCC1—Irinotecan Pathway—APC—brain cancer	0.000332	0.00806	CbGpPWpGaD
Glyburide—Vision blurred—Temozolomide—brain cancer	0.000328	0.00324	CcSEcCtD
Glyburide—Tremor—Temozolomide—brain cancer	0.000326	0.00322	CcSEcCtD
Glyburide—SLCO1A2—endocrine gland—brain cancer	0.000326	0.00406	CbGeAlD
Glyburide—Dyspnoea—Hydroxyurea—brain cancer	0.000324	0.0032	CcSEcCtD
Glyburide—ABCC8—brain—brain cancer	0.000324	0.00403	CbGeAlD
Glyburide—Leukopenia—Carmustine—brain cancer	0.000323	0.00319	CcSEcCtD
Glyburide—SLCO1A2—head—brain cancer	0.000322	0.00401	CbGeAlD
Glyburide—Anaemia—Temozolomide—brain cancer	0.000322	0.00318	CcSEcCtD
Glyburide—Diarrhoea—Procarbazine—brain cancer	0.000322	0.00318	CcSEcCtD
Glyburide—Dyspepsia—Hydroxyurea—brain cancer	0.00032	0.00316	CcSEcCtD
Glyburide—SLCO2B1—central nervous system—brain cancer	0.000319	0.00397	CbGeAlD
Glyburide—Angioedema—Temozolomide—brain cancer	0.000318	0.00314	CcSEcCtD
Glyburide—Decreased appetite—Hydroxyurea—brain cancer	0.000316	0.00312	CcSEcCtD
Glyburide—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000315	0.00764	CbGpPWpGaD
Glyburide—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000314	0.0031	CcSEcCtD
Glyburide—Convulsion—Carmustine—brain cancer	0.000312	0.00308	CcSEcCtD
Glyburide—SLCO2B1—cerebellum—brain cancer	0.000312	0.00388	CbGeAlD
Glyburide—Leukopenia—Temozolomide—brain cancer	0.000312	0.00308	CcSEcCtD
Glyburide—SLC15A2—midbrain—brain cancer	0.000308	0.00383	CbGeAlD
Glyburide—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000308	0.00746	CbGpPWpGaD
Glyburide—Myalgia—Carmustine—brain cancer	0.000307	0.00303	CcSEcCtD
Glyburide—ABCC2—endocrine gland—brain cancer	0.000304	0.00378	CbGeAlD
Glyburide—CPT1A—PPAR Alpha Pathway—MYC—brain cancer	0.000304	0.00736	CbGpPWpGaD
Glyburide—Convulsion—Temozolomide—brain cancer	0.000302	0.00298	CcSEcCtD
Glyburide—SLC15A2—spinal cord—brain cancer	0.000301	0.00374	CbGeAlD
Glyburide—Feeling abnormal—Hydroxyurea—brain cancer	0.0003	0.00296	CcSEcCtD
Glyburide—Eye disorder—Etoposide—brain cancer	0.000299	0.00295	CcSEcCtD
Glyburide—Vomiting—Procarbazine—brain cancer	0.000299	0.00295	CcSEcCtD
Glyburide—Confusional state—Carmustine—brain cancer	0.000297	0.00293	CcSEcCtD
Glyburide—Myalgia—Temozolomide—brain cancer	0.000296	0.00293	CcSEcCtD
Glyburide—Arthralgia—Temozolomide—brain cancer	0.000296	0.00293	CcSEcCtD
Glyburide—Rash—Procarbazine—brain cancer	0.000296	0.00293	CcSEcCtD
Glyburide—Dermatitis—Procarbazine—brain cancer	0.000296	0.00292	CcSEcCtD
Glyburide—Headache—Procarbazine—brain cancer	0.000294	0.00291	CcSEcCtD
Glyburide—Oedema—Carmustine—brain cancer	0.000294	0.0029	CcSEcCtD
Glyburide—SLCO1A2—central nervous system—brain cancer	0.000294	0.00366	CbGeAlD
Glyburide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000293	0.00711	CbGpPWpGaD
Glyburide—ABCG2—Irinotecan Pathway—APC—brain cancer	0.000292	0.00709	CbGpPWpGaD
Glyburide—ABCC9—Transmembrane transport of small molecules—S100A10—brain cancer	0.000292	0.00708	CbGpPWpGaD
Glyburide—Thrombocytopenia—Carmustine—brain cancer	0.000288	0.00284	CcSEcCtD
Glyburide—SLCO1A2—cerebellum—brain cancer	0.000287	0.00357	CbGeAlD
Glyburide—Confusional state—Temozolomide—brain cancer	0.000287	0.00283	CcSEcCtD
Glyburide—ABCG2—pituitary gland—brain cancer	0.000286	0.00356	CbGeAlD
Glyburide—Oedema—Temozolomide—brain cancer	0.000284	0.00281	CcSEcCtD
Glyburide—Alopecia—Etoposide—brain cancer	0.000283	0.00279	CcSEcCtD
Glyburide—ABCA1—Selenium Micronutrient Network—SOD2—brain cancer	0.000281	0.00682	CbGpPWpGaD
Glyburide—Anorexia—Carmustine—brain cancer	0.00028	0.00277	CcSEcCtD
Glyburide—Nausea—Procarbazine—brain cancer	0.000279	0.00276	CcSEcCtD
Glyburide—Nervous system disorder—Temozolomide—brain cancer	0.000279	0.00275	CcSEcCtD
Glyburide—Thrombocytopenia—Temozolomide—brain cancer	0.000278	0.00275	CcSEcCtD
Glyburide—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000276	0.00669	CbGpPWpGaD
Glyburide—ABCG2—medulla oblongata—brain cancer	0.000276	0.00343	CbGeAlD
Glyburide—Hypotension—Carmustine—brain cancer	0.000275	0.00271	CcSEcCtD
Glyburide—Hyperhidrosis—Temozolomide—brain cancer	0.000275	0.00271	CcSEcCtD
Glyburide—ABCC3—brain—brain cancer	0.000272	0.00338	CbGeAlD
Glyburide—Anorexia—Temozolomide—brain cancer	0.000271	0.00268	CcSEcCtD
Glyburide—SLC15A2—endocrine gland—brain cancer	0.000271	0.00337	CbGeAlD
Glyburide—Hypersensitivity—Hydroxyurea—brain cancer	0.000268	0.00265	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Carmustine—brain cancer	0.000268	0.00265	CcSEcCtD
Glyburide—SLC15A2—head—brain cancer	0.000267	0.00332	CbGeAlD
Glyburide—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000265	0.00644	CbGpPWpGaD
Glyburide—Paraesthesia—Carmustine—brain cancer	0.000264	0.00261	CcSEcCtD
Glyburide—Dyspnoea—Carmustine—brain cancer	0.000262	0.00259	CcSEcCtD
Glyburide—Asthenia—Hydroxyurea—brain cancer	0.000261	0.00258	CcSEcCtD
Glyburide—CYP2C19—endocrine gland—brain cancer	0.000261	0.00325	CbGeAlD
Glyburide—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000259	0.00256	CcSEcCtD
Glyburide—Anaemia—Etoposide—brain cancer	0.000258	0.00254	CcSEcCtD
Glyburide—Decreased appetite—Carmustine—brain cancer	0.000256	0.00252	CcSEcCtD
Glyburide—Paraesthesia—Temozolomide—brain cancer	0.000255	0.00252	CcSEcCtD
Glyburide—Gastrointestinal disorder—Carmustine—brain cancer	0.000254	0.00251	CcSEcCtD
Glyburide—SLCO2B1—brain—brain cancer	0.000253	0.00315	CbGeAlD
Glyburide—Dyspnoea—Temozolomide—brain cancer	0.000253	0.0025	CcSEcCtD
Glyburide—CPT1A—AMPK Signaling—PIK3CG—brain cancer	0.000253	0.00613	CbGpPWpGaD
Glyburide—ABCG2—midbrain—brain cancer	0.000252	0.00314	CbGeAlD
Glyburide—ABCA1—Vitamin B12 Metabolism—RELA—brain cancer	0.000251	0.0061	CbGpPWpGaD
Glyburide—Dyspepsia—Temozolomide—brain cancer	0.00025	0.00247	CcSEcCtD
Glyburide—Leukopenia—Etoposide—brain cancer	0.000249	0.00246	CcSEcCtD
Glyburide—Diarrhoea—Hydroxyurea—brain cancer	0.000249	0.00246	CcSEcCtD
Glyburide—Decreased appetite—Temozolomide—brain cancer	0.000247	0.00244	CcSEcCtD
Glyburide—ABCG2—spinal cord—brain cancer	0.000246	0.00306	CbGeAlD
Glyburide—Gastrointestinal disorder—Temozolomide—brain cancer	0.000245	0.00242	CcSEcCtD
Glyburide—SLC15A2—central nervous system—brain cancer	0.000244	0.00303	CbGeAlD
Glyburide—Feeling abnormal—Carmustine—brain cancer	0.000242	0.00239	CcSEcCtD
Glyburide—Convulsion—Etoposide—brain cancer	0.000241	0.00238	CcSEcCtD
Glyburide—Gastrointestinal pain—Carmustine—brain cancer	0.00024	0.00237	CcSEcCtD
Glyburide—SLC15A2—cerebellum—brain cancer	0.000238	0.00297	CbGeAlD
Glyburide—ABCC1—cerebellum—brain cancer	0.000236	0.00293	CbGeAlD
Glyburide—Feeling abnormal—Temozolomide—brain cancer	0.000234	0.00231	CcSEcCtD
Glyburide—SLCO1A2—brain—brain cancer	0.000233	0.0029	CbGeAlD
Glyburide—Abdominal pain—Carmustine—brain cancer	0.000232	0.0023	CcSEcCtD
Glyburide—Gastrointestinal pain—Temozolomide—brain cancer	0.000232	0.00229	CcSEcCtD
Glyburide—ALB—brain—brain cancer	0.000232	0.00289	CbGeAlD
Glyburide—Vomiting—Hydroxyurea—brain cancer	0.000231	0.00228	CcSEcCtD
Glyburide—CPT1A—SIDS Susceptibility Pathways—ESR2—brain cancer	0.00023	0.00557	CbGpPWpGaD
Glyburide—Rash—Hydroxyurea—brain cancer	0.000229	0.00226	CcSEcCtD
Glyburide—Confusional state—Etoposide—brain cancer	0.000229	0.00226	CcSEcCtD
Glyburide—Dermatitis—Hydroxyurea—brain cancer	0.000229	0.00226	CcSEcCtD
Glyburide—Headache—Hydroxyurea—brain cancer	0.000228	0.00225	CcSEcCtD
Glyburide—Urticaria—Temozolomide—brain cancer	0.000226	0.00223	CcSEcCtD
Glyburide—Abdominal pain—Temozolomide—brain cancer	0.000225	0.00222	CcSEcCtD
Glyburide—Thrombocytopenia—Etoposide—brain cancer	0.000223	0.0022	CcSEcCtD
Glyburide—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000222	0.00538	CbGpPWpGaD
Glyburide—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000221	0.00535	CbGpPWpGaD
Glyburide—Hyperhidrosis—Etoposide—brain cancer	0.00022	0.00217	CcSEcCtD
Glyburide—Anorexia—Etoposide—brain cancer	0.000217	0.00214	CcSEcCtD
Glyburide—Hypersensitivity—Carmustine—brain cancer	0.000217	0.00214	CcSEcCtD
Glyburide—Nausea—Hydroxyurea—brain cancer	0.000216	0.00213	CcSEcCtD
Glyburide—Hypotension—Etoposide—brain cancer	0.000213	0.0021	CcSEcCtD
Glyburide—Asthenia—Carmustine—brain cancer	0.000211	0.00208	CcSEcCtD
Glyburide—Hypersensitivity—Temozolomide—brain cancer	0.000209	0.00207	CcSEcCtD
Glyburide—ABCA1—Folate Metabolism—RELA—brain cancer	0.000205	0.00496	CbGpPWpGaD
Glyburide—Paraesthesia—Etoposide—brain cancer	0.000204	0.00202	CcSEcCtD
Glyburide—Asthenia—Temozolomide—brain cancer	0.000204	0.00201	CcSEcCtD
Glyburide—Dyspnoea—Etoposide—brain cancer	0.000203	0.002	CcSEcCtD
Glyburide—CYP2C9—endocrine gland—brain cancer	0.000202	0.00252	CbGeAlD
Glyburide—ABCG2—HIF-2-alpha transcription factor network—SIRT1—brain cancer	0.000202	0.0049	CbGpPWpGaD
Glyburide—Diarrhoea—Carmustine—brain cancer	0.000201	0.00199	CcSEcCtD
Glyburide—Pruritus—Temozolomide—brain cancer	0.000201	0.00199	CcSEcCtD
Glyburide—Decreased appetite—Etoposide—brain cancer	0.000198	0.00195	CcSEcCtD
Glyburide—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000198	0.00479	CbGpPWpGaD
Glyburide—Gastrointestinal disorder—Etoposide—brain cancer	0.000196	0.00194	CcSEcCtD
Glyburide—ABCG2—cerebellum—brain cancer	0.000195	0.00243	CbGeAlD
Glyburide—Diarrhoea—Temozolomide—brain cancer	0.000194	0.00192	CcSEcCtD
Glyburide—SLC15A2—brain—brain cancer	0.000194	0.00241	CbGeAlD
Glyburide—ABCC1—brain—brain cancer	0.000191	0.00238	CbGeAlD
Glyburide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000191	0.00462	CbGpPWpGaD
Glyburide—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00019	0.0046	CbGpPWpGaD
Glyburide—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000188	0.00456	CbGpPWpGaD
Glyburide—Feeling abnormal—Etoposide—brain cancer	0.000187	0.00185	CcSEcCtD
Glyburide—Vomiting—Carmustine—brain cancer	0.000187	0.00185	CcSEcCtD
Glyburide—CFTR—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000186	0.00452	CbGpPWpGaD
Glyburide—Gastrointestinal pain—Etoposide—brain cancer	0.000186	0.00184	CcSEcCtD
Glyburide—Rash—Carmustine—brain cancer	0.000185	0.00183	CcSEcCtD
Glyburide—Dermatitis—Carmustine—brain cancer	0.000185	0.00183	CcSEcCtD
Glyburide—ABCA1—Folate Metabolism—IL2—brain cancer	0.000184	0.00447	CbGpPWpGaD
Glyburide—Headache—Carmustine—brain cancer	0.000184	0.00182	CcSEcCtD
Glyburide—Vomiting—Temozolomide—brain cancer	0.000181	0.00178	CcSEcCtD
Glyburide—Urticaria—Etoposide—brain cancer	0.000181	0.00178	CcSEcCtD
Glyburide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000181	0.00438	CbGpPWpGaD
Glyburide—Abdominal pain—Etoposide—brain cancer	0.00018	0.00178	CcSEcCtD
Glyburide—Rash—Temozolomide—brain cancer	0.000179	0.00177	CcSEcCtD
Glyburide—Dermatitis—Temozolomide—brain cancer	0.000179	0.00177	CcSEcCtD
Glyburide—CPT1A—SIDS Susceptibility Pathways—HES1—brain cancer	0.000178	0.00432	CbGpPWpGaD
Glyburide—Headache—Temozolomide—brain cancer	0.000178	0.00176	CcSEcCtD
Glyburide—CPT1A—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000176	0.00427	CbGpPWpGaD
Glyburide—ABCA1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000176	0.00427	CbGpPWpGaD
Glyburide—Nausea—Carmustine—brain cancer	0.000175	0.00172	CcSEcCtD
Glyburide—ABCB1—telencephalon—brain cancer	0.000173	0.00215	CbGeAlD
Glyburide—Nausea—Temozolomide—brain cancer	0.000169	0.00167	CcSEcCtD
Glyburide—Hypersensitivity—Etoposide—brain cancer	0.000168	0.00165	CcSEcCtD
Glyburide—Asthenia—Etoposide—brain cancer	0.000163	0.00161	CcSEcCtD
Glyburide—ABCA1—Selenium Micronutrient Network—RELA—brain cancer	0.000163	0.00394	CbGpPWpGaD
Glyburide—Pruritus—Etoposide—brain cancer	0.000161	0.00159	CcSEcCtD
Glyburide—ABCG2—brain—brain cancer	0.000158	0.00197	CbGeAlD
Glyburide—Diarrhoea—Etoposide—brain cancer	0.000156	0.00154	CcSEcCtD
Glyburide—ABCC1—S1P1 pathway—VEGFA—brain cancer	0.000156	0.00377	CbGpPWpGaD
Glyburide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000155	0.00375	CbGpPWpGaD
Glyburide—CYP3A4—endocrine gland—brain cancer	0.000154	0.00192	CbGeAlD
Glyburide—CPT1A—Circadian rythm related genes—SIRT1—brain cancer	0.000151	0.00366	CbGpPWpGaD
Glyburide—Vomiting—Etoposide—brain cancer	0.000145	0.00143	CcSEcCtD
Glyburide—ABCB1—gonad—brain cancer	0.000145	0.0018	CbGeAlD
Glyburide—Rash—Etoposide—brain cancer	0.000143	0.00142	CcSEcCtD
Glyburide—Dermatitis—Etoposide—brain cancer	0.000143	0.00141	CcSEcCtD
Glyburide—Headache—Etoposide—brain cancer	0.000142	0.00141	CcSEcCtD
Glyburide—ABCB1—pituitary gland—brain cancer	0.000141	0.00175	CbGeAlD
Glyburide—CYP3A4—central nervous system—brain cancer	0.000139	0.00173	CbGeAlD
Glyburide—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.000138	0.00336	CbGpPWpGaD
Glyburide—ABCB1—medulla oblongata—brain cancer	0.000136	0.00169	CbGeAlD
Glyburide—Nausea—Etoposide—brain cancer	0.000135	0.00133	CcSEcCtD
Glyburide—ABCC9—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000135	0.00327	CbGpPWpGaD
Glyburide—SLCO2B1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000134	0.00326	CbGpPWpGaD
Glyburide—CPT1A—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000129	0.00313	CbGpPWpGaD
Glyburide—ABCA1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000129	0.00313	CbGpPWpGaD
Glyburide—ABCC8—Transmembrane transport of small molecules—S100A10—brain cancer	0.000125	0.00303	CbGpPWpGaD
Glyburide—ABCB1—midbrain—brain cancer	0.000124	0.00155	CbGeAlD
Glyburide—ABCB1—spinal cord—brain cancer	0.000121	0.00151	CbGeAlD
Glyburide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.00012	0.00291	CbGpPWpGaD
Glyburide—ABCA1—Folate Metabolism—TP53—brain cancer	0.000118	0.00287	CbGpPWpGaD
Glyburide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000115	0.00278	CbGpPWpGaD
Glyburide—CPT1A—AMPK Signaling—TP53—brain cancer	0.000114	0.00277	CbGpPWpGaD
Glyburide—CPT1A—Circadian rythm related genes—CDK4—brain cancer	0.000114	0.00277	CbGpPWpGaD
Glyburide—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000113	0.00274	CbGpPWpGaD
Glyburide—SLC22A7—Fluoropyrimidine Activity—TP53—brain cancer	0.000113	0.00273	CbGpPWpGaD
Glyburide—SLC15A2—Transmembrane transport of small molecules—S100A10—brain cancer	0.000113	0.00273	CbGpPWpGaD
Glyburide—SLC22A7—Transmembrane transport of small molecules—S100A10—brain cancer	0.00011	0.00268	CbGpPWpGaD
Glyburide—ABCB1—endocrine gland—brain cancer	0.000109	0.00136	CbGeAlD
Glyburide—ABCB1—head—brain cancer	0.000108	0.00134	CbGeAlD
Glyburide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000107	0.00259	CbGpPWpGaD
Glyburide—SLC15A1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000104	0.00253	CbGpPWpGaD
Glyburide—ABCB1—central nervous system—brain cancer	9.84e-05	0.00122	CbGeAlD
Glyburide—CYP3A4—Irinotecan Pathway—APC—brain cancer	9.74e-05	0.00236	CbGpPWpGaD
Glyburide—ABCC3—Fluoropyrimidine Activity—TP53—brain cancer	9.65e-05	0.00234	CbGpPWpGaD
Glyburide—ABCB1—cerebellum—brain cancer	9.62e-05	0.0012	CbGeAlD
Glyburide—ABCC3—Transmembrane transport of small molecules—S100A10—brain cancer	9.47e-05	0.0023	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—MPL—brain cancer	9.42e-05	0.00228	CbGpPWpGaD
Glyburide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	9.29e-05	0.00225	CbGpPWpGaD
Glyburide—CPT1A—SIDS Susceptibility Pathways—CTNNB1—brain cancer	8.94e-05	0.00217	CbGpPWpGaD
Glyburide—ALB—Vitamin B12 Metabolism—SOD2—brain cancer	8.67e-05	0.0021	CbGpPWpGaD
Glyburide—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	8.63e-05	0.00209	CbGpPWpGaD
Glyburide—ABCB11—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	8.61e-05	0.00209	CbGpPWpGaD
Glyburide—ABCG2—HIF-2-alpha transcription factor network—VEGFA—brain cancer	8.59e-05	0.00208	CbGpPWpGaD
Glyburide—ABCC3—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	8.25e-05	0.002	CbGpPWpGaD
Glyburide—SLCO1A2—Transmembrane transport of small molecules—S100A10—brain cancer	8.25e-05	0.002	CbGpPWpGaD
Glyburide—CYP2C19—Biological oxidations—CYP2C9—brain cancer	8.21e-05	0.00199	CbGpPWpGaD
Glyburide—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	8.1e-05	0.00196	CbGpPWpGaD
Glyburide—CPT1A—SIDS Susceptibility Pathways—VEGFA—brain cancer	7.87e-05	0.00191	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—CYP2C9—brain cancer	7.85e-05	0.0019	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—CYP2C9—brain cancer	7.85e-05	0.0019	CbGpPWpGaD
Glyburide—ABCB1—brain—brain cancer	7.81e-05	0.000972	CbGeAlD
Glyburide—SLC22A6—Transmembrane transport of small molecules—S100A10—brain cancer	7.75e-05	0.00188	CbGpPWpGaD
Glyburide—ABCC2—Transmembrane transport of small molecules—S100A10—brain cancer	7.51e-05	0.00182	CbGpPWpGaD
Glyburide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	7.48e-05	0.00181	CbGpPWpGaD
Glyburide—ABCC1—Transmembrane transport of small molecules—S100A10—brain cancer	7.42e-05	0.0018	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	7.19e-05	0.00174	CbGpPWpGaD
Glyburide—ALB—Folate Metabolism—SOD2—brain cancer	7.05e-05	0.00171	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—BSG—brain cancer	6.67e-05	0.00162	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—BSG—brain cancer	6.67e-05	0.00162	CbGpPWpGaD
Glyburide—ABCG2—Fluoropyrimidine Activity—TP53—brain cancer	6.65e-05	0.00161	CbGpPWpGaD
Glyburide—ABCG2—Transmembrane transport of small molecules—S100A10—brain cancer	6.53e-05	0.00158	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	6.47e-05	0.00157	CbGpPWpGaD
Glyburide—ABCB11—Metabolism of lipids and lipoproteins—IDH1—brain cancer	6.29e-05	0.00153	CbGpPWpGaD
Glyburide—SLCO2B1—Transmembrane transport of small molecules—TRPC6—brain cancer	6.21e-05	0.00151	CbGpPWpGaD
Glyburide—ABCC3—Metabolism of lipids and lipoproteins—IDH1—brain cancer	6.03e-05	0.00146	CbGpPWpGaD
Glyburide—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	5.9e-05	0.00143	CbGpPWpGaD
Glyburide—ABCC8—Transmembrane transport of small molecules—TRPC6—brain cancer	5.77e-05	0.0014	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—IDH1—brain cancer	5.74e-05	0.00139	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—IDH1—brain cancer	5.74e-05	0.00139	CbGpPWpGaD
Glyburide—ALB—Selenium Micronutrient Network—SOD2—brain cancer	5.6e-05	0.00136	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.25e-05	0.00127	CbGpPWpGaD
Glyburide—SLC15A2—Transmembrane transport of small molecules—TRPC6—brain cancer	5.2e-05	0.00126	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—PDGFRA—brain cancer	5.1e-05	0.00124	CbGpPWpGaD
Glyburide—SLC22A7—Transmembrane transport of small molecules—TRPC6—brain cancer	5.1e-05	0.00124	CbGpPWpGaD
Glyburide—ABCC1—Disease—DTX2—brain cancer	5.09e-05	0.00123	CbGpPWpGaD
Glyburide—ABCG2—HIF-1-alpha transcription factor network—VEGFA—brain cancer	5.06e-05	0.00123	CbGpPWpGaD
Glyburide—ALB—Vitamin B12 Metabolism—RELA—brain cancer	5.01e-05	0.00121	CbGpPWpGaD
Glyburide—CYP3A4—Biological oxidations—CYP2C9—brain cancer	4.94e-05	0.0012	CbGpPWpGaD
Glyburide—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	4.87e-05	0.00118	CbGpPWpGaD
Glyburide—CPT1A—Circadian rythm related genes—TP53—brain cancer	4.85e-05	0.00118	CbGpPWpGaD
Glyburide—ALB—Hemostasis—MPL—brain cancer	4.85e-05	0.00118	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—CYP2C9—brain cancer	4.85e-05	0.00118	CbGpPWpGaD
Glyburide—SLC15A1—Transmembrane transport of small molecules—TRPC6—brain cancer	4.82e-05	0.00117	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.73e-05	0.00115	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—CYP2C9—brain cancer	4.7e-05	0.00114	CbGpPWpGaD
Glyburide—ABCA1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.67e-05	0.00113	CbGpPWpGaD
Glyburide—CPT1A—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.67e-05	0.00113	CbGpPWpGaD
Glyburide—ALB—Hemostasis—S100A10—brain cancer	4.65e-05	0.00113	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—ENO2—brain cancer	4.54e-05	0.0011	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—ENO2—brain cancer	4.54e-05	0.0011	CbGpPWpGaD
Glyburide—ABCC3—Transmembrane transport of small molecules—TRPC6—brain cancer	4.37e-05	0.00106	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	4.26e-05	0.00103	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—TRPC6—brain cancer	4.17e-05	0.00101	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—BSG—brain cancer	4.12e-05	0.001	CbGpPWpGaD
Glyburide—ALB—Folate Metabolism—RELA—brain cancer	4.08e-05	0.000988	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	4.04e-05	0.000979	CbGpPWpGaD
Glyburide—ALB—Transmembrane transport of small molecules—S100A10—brain cancer	4.03e-05	0.000977	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—BSG—brain cancer	4e-05	0.00097	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—CYP2C9—brain cancer	3.83e-05	0.00093	CbGpPWpGaD
Glyburide—SLCO1A2—Transmembrane transport of small molecules—TRPC6—brain cancer	3.81e-05	0.000924	CbGpPWpGaD
Glyburide—ABCC1—Disease—HES5—brain cancer	3.74e-05	0.000906	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—CYP2C9—brain cancer	3.68e-05	0.000891	CbGpPWpGaD
Glyburide—ALB—Folate Metabolism—IL2—brain cancer	3.67e-05	0.00089	CbGpPWpGaD
Glyburide—SLC22A6—Transmembrane transport of small molecules—TRPC6—brain cancer	3.58e-05	0.000868	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—IDH1—brain cancer	3.55e-05	0.00086	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	3.53e-05	0.000856	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.51e-05	0.000852	CbGpPWpGaD
Glyburide—ABCC2—Transmembrane transport of small molecules—TRPC6—brain cancer	3.47e-05	0.000841	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—IDH1—brain cancer	3.44e-05	0.000834	CbGpPWpGaD
Glyburide—ABCC1—Transmembrane transport of small molecules—TRPC6—brain cancer	3.43e-05	0.000831	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	3.41e-05	0.000826	CbGpPWpGaD
Glyburide—ALB—Hemostasis—BSG—brain cancer	3.28e-05	0.000795	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—BSG—brain cancer	3.26e-05	0.000791	CbGpPWpGaD
Glyburide—ALB—Selenium Micronutrient Network—RELA—brain cancer	3.24e-05	0.000785	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—CYP2C9—brain cancer	3.2e-05	0.000776	CbGpPWpGaD
Glyburide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	3.19e-05	0.000774	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.15e-05	0.000764	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—BSG—brain cancer	3.12e-05	0.000758	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—VAV1—brain cancer	3.12e-05	0.000758	CbGpPWpGaD
Glyburide—ABCG2—Transmembrane transport of small molecules—TRPC6—brain cancer	3.02e-05	0.000731	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—CYP2C9—brain cancer	2.88e-05	0.000698	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—ENO2—brain cancer	2.8e-05	0.00068	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—IDH1—brain cancer	2.8e-05	0.00068	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	2.8e-05	0.000679	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—IL2—brain cancer	2.79e-05	0.000676	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	2.74e-05	0.000665	CbGpPWpGaD
Glyburide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	2.73e-05	0.000663	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—BSG—brain cancer	2.72e-05	0.00066	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—ENO2—brain cancer	2.72e-05	0.000659	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	2.71e-05	0.000657	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—IDH1—brain cancer	2.69e-05	0.000652	CbGpPWpGaD
Glyburide—ALB—Platelet degranulation—VEGFA—brain cancer	2.67e-05	0.000649	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.57e-05	0.000623	CbGpPWpGaD
Glyburide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	2.55e-05	0.000618	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—CYP2C9—brain cancer	2.53e-05	0.000615	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	2.52e-05	0.000611	CbGpPWpGaD
Glyburide—ABCC1—Disease—IDH1—brain cancer	2.51e-05	0.00061	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—BSG—brain cancer	2.45e-05	0.000594	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	2.4e-05	0.000582	CbGpPWpGaD
Glyburide—ABCC1—Disease—HEY1—brain cancer	2.38e-05	0.000578	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—VEGFA—brain cancer	2.37e-05	0.000574	CbGpPWpGaD
Glyburide—ALB—Folate Metabolism—TP53—brain cancer	2.36e-05	0.000572	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—IDH1—brain cancer	2.34e-05	0.000567	CbGpPWpGaD
Glyburide—ABCC1—Disease—DLL1—brain cancer	2.34e-05	0.000567	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.3e-05	0.000559	CbGpPWpGaD
Glyburide—ABCB11—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.28e-05	0.000554	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—ENO2—brain cancer	2.22e-05	0.000537	CbGpPWpGaD
Glyburide—ABCC3—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.19e-05	0.000531	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—BSG—brain cancer	2.15e-05	0.000523	CbGpPWpGaD
Glyburide—ALB—Hemostasis—TRPC6—brain cancer	2.15e-05	0.000521	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—ENO2—brain cancer	2.12e-05	0.000515	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—IDH1—brain cancer	2.11e-05	0.000511	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.1e-05	0.00051	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—PIK3CG—brain cancer	2.08e-05	0.000505	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—PIK3CG—brain cancer	2.08e-05	0.000505	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	2.08e-05	0.000503	CbGpPWpGaD
Glyburide—ABCC1—Disease—SHH—brain cancer	1.99e-05	0.000482	CbGpPWpGaD
Glyburide—ABCC1—Disease—ENO2—brain cancer	1.99e-05	0.000482	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	1.98e-05	0.000481	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	1.95e-05	0.000474	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.91e-05	0.000462	CbGpPWpGaD
Glyburide—ALB—Transmembrane transport of small molecules—TRPC6—brain cancer	1.86e-05	0.000451	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—IDH1—brain cancer	1.85e-05	0.000449	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—ENO2—brain cancer	1.85e-05	0.000449	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.71e-05	0.000416	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—ENO2—brain cancer	1.66e-05	0.000404	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.63e-05	0.000395	CbGpPWpGaD
Glyburide—ALB—Hemostasis—VAV1—brain cancer	1.61e-05	0.000391	CbGpPWpGaD
Glyburide—ALB—Metabolism—CYP2C9—brain cancer	1.56e-05	0.000379	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.52e-05	0.000368	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—ENO2—brain cancer	1.46e-05	0.000355	CbGpPWpGaD
Glyburide—ABCC1—Disease—VAV1—brain cancer	1.44e-05	0.000348	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CYP2C9—brain cancer	1.4e-05	0.00034	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—IL2—brain cancer	1.4e-05	0.000339	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CYP2C9—brain cancer	1.37e-05	0.000332	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.34e-05	0.000325	CbGpPWpGaD
Glyburide—ALB—Metabolism—BSG—brain cancer	1.33e-05	0.000322	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.33e-05	0.000322	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PIK3CG—brain cancer	1.29e-05	0.000312	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PIK3CG—brain cancer	1.25e-05	0.000302	CbGpPWpGaD
Glyburide—ABCC1—Disease—HES1—brain cancer	1.23e-05	0.0003	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—BSG—brain cancer	1.19e-05	0.000289	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—VEGFA—brain cancer	1.19e-05	0.000288	CbGpPWpGaD
Glyburide—ABCC1—Disease—PDGFRA—brain cancer	1.18e-05	0.000285	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.17e-05	0.000283	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—BSG—brain cancer	1.16e-05	0.000283	CbGpPWpGaD
Glyburide—ALB—Metabolism—IDH1—brain cancer	1.14e-05	0.000277	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—BSG—brain cancer	1.09e-05	0.000264	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.07e-05	0.000261	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.05e-05	0.000255	CbGpPWpGaD
Glyburide—ABCC1—Disease—IRS2—brain cancer	1.03e-05	0.00025	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—IDH1—brain cancer	1.03e-05	0.000249	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PIK3CG—brain cancer	1.02e-05	0.000248	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PIK3CG—brain cancer	1.02e-05	0.000247	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—IDH1—brain cancer	1e-05	0.000243	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PIK3CG—brain cancer	9.74e-06	0.000236	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—IDH1—brain cancer	9.36e-06	0.000227	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.31e-06	0.000226	CbGpPWpGaD
Glyburide—ABCC1—Disease—APC—brain cancer	9.12e-06	0.000221	CbGpPWpGaD
Glyburide—ALB—Metabolism—ENO2—brain cancer	9.04e-06	0.000219	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	8.83e-06	0.000214	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3CG—brain cancer	8.49e-06	0.000206	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP2C9—brain cancer	8.44e-06	0.000205	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.36e-06	0.000203	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ENO2—brain cancer	8.11e-06	0.000197	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ENO2—brain cancer	7.92e-06	0.000192	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CG—brain cancer	7.64e-06	0.000185	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.62e-06	0.000185	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ENO2—brain cancer	7.4e-06	0.000179	CbGpPWpGaD
Glyburide—ALB—Hemostasis—IL2—brain cancer	7.2e-06	0.000175	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—BSG—brain cancer	7.18e-06	0.000174	CbGpPWpGaD
Glyburide—ABCC1—Disease—ERBB2—brain cancer	7.08e-06	0.000172	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CG—brain cancer	6.72e-06	0.000163	CbGpPWpGaD
Glyburide—ABCC1—Disease—CTNNB1—brain cancer	6.19e-06	0.00015	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—IDH1—brain cancer	6.17e-06	0.00015	CbGpPWpGaD
Glyburide—ALB—Hemostasis—VEGFA—brain cancer	6.12e-06	0.000148	CbGpPWpGaD
Glyburide—ABCC1—Disease—STAT3—brain cancer	5.4e-06	0.000131	CbGpPWpGaD
Glyburide—ABCC1—Disease—MYC—brain cancer	5.02e-06	0.000122	CbGpPWpGaD
Glyburide—ABCC1—Disease—EGFR—brain cancer	4.91e-06	0.000119	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ENO2—brain cancer	4.88e-06	0.000118	CbGpPWpGaD
Glyburide—ALB—Hemostasis—TP53—brain cancer	4.62e-06	0.000112	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CG—brain cancer	4.15e-06	0.000101	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CG—brain cancer	3.72e-06	9.03e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CG—brain cancer	3.63e-06	8.81e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CG—brain cancer	3.39e-06	8.23e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CG—brain cancer	2.24e-06	5.43e-05	CbGpPWpGaD
